tariquidar has been researched along with isatin in 1 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (isatin) | Trials (isatin) | Recent Studies (post-2010) (isatin) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 1,093 | 3 | 575 |
| Protein | Taxonomy | tariquidar (IC50) | isatin (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 8.43 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 5.2478 | |
| Secreted chorismate mutase | Mycobacterium tuberculosis H37Rv | 1.08 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigoreva, T; Novikova, D; Romanova, A; Sagaidak, A; Tribulovich, V; Vorona, S | 1 |
1 other study(ies) available for tariquidar and isatin
| Article | Year |
|---|---|
Mdm2 inhibitors as a platform for the design of P-glycoprotein inhibitors.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Computer Simulation; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Isatin; Models, Molecular; Piperazines; Protein Binding; Proto-Oncogene Proteins c-mdm2; Quinolines; Structure-Activity Relationship | 2020 |